1TB.F - Orphazyme A/S

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
36,193
36,193
0
-
Operating expenses
Research development
229,942
229,942
261,136
285,413
Selling general and administrative
391,395
421,443
342,199
49,842
Total operating expenses
639,448
669,496
608,534
335,954
Operating income or loss
-603,255
-633,303
-608,534
-335,954
Interest expense
9,458
9,458
14,114
4,803
Total other income/expenses net
-
11,391
-12,406
-2,477
Income before tax
-601,400
-631,480
-635,161
-342,997
Income tax expense
-5,416
-4,941
-1,915
-5,500
Income from continuing operations
-595,984
-626,539
-633,246
-337,497
Net income
-99,776
-626,539
-633,246
-337,497
Net income available to common shareholders
-99,776
-626,539
-633,246
-337,497
Basic EPS
-
-17.94
-22.32
-16.85
Diluted EPS
-
-17.94
-22.32
-16.85
Basic average shares
-
34,925
28,366
20,025
Diluted average shares
-
34,925
28,366
20,025
EBITDA
-
-603,911
-615,847
-334,391